Shane Storey
Stock Analyst at Canaccord Genuity
(3.15)
# 2,712
Out of 4,668 analysts
343
Total ratings
46.8%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $30.00 | $15.92 | +88.44% | 55 | Jul 22, 2026 | |
| ASX: ACW Actinogen Medical Limited | Maintained: Buy | $0.08 | $0.04 | +81.82% | 5 | Jul 21, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $44.50 → $40.00 | $32.15 | +24.44% | 21 | Jul 21, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $45.21 → $44.01 | $43.08 | +2.15% | 16 | May 27, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $180.00 → $106.31 | $167.91 | -36.68% | 28 | May 12, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.16 → $1.35 | $0.57 | +136.84% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $295.00 → $120.00 | $136.65 | -12.18% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.69 → $0.86 | $0.73 | +17.81% | 20 | Apr 29, 2026 | |
| ASX: OCC Orthocell Limited | Maintained: Buy | $1.33 → $1.26 | $0.81 | +55.56% | 2 | Apr 20, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $1.00 | $0.35 | +185.71% | 22 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.43 → $5.55 | $3.57 | +55.68% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.57 | $2.25 | +14.22% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.62 → $1.58 | $1.07 | +48.36% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.92 | -17.81% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.07 → $0.06 | $0.01 | +1,100.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350.00 | $197.02 | +77.65% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.85 → $0.80 | $0.28 | +185.71% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37.00 | $44.96 | -17.70% | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 | $10.45 | +214.26% | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.81 | $0.27 | +940.74% | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.20 | $0.05 | +2,164.15% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $2.20 | +36.67% | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.50 | $22.47 | +17.94% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.50 | $2.45 | n/a | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $3.28 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.55 | $0.40 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $1.16 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.50 → $0.55 | $0.11 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.75 | $0.01 | n/a | 1 | Jun 1, 2022 |
Telix Pharmaceuticals Limited
Jul 22, 2026
Maintained: Buy
Price Target: $30.00
Current: $15.92
Upside: +88.44%
Actinogen Medical Limited
Jul 21, 2026
Maintained: Buy
Price Target: $0.08
Current: $0.04
Upside: +81.82%
ResMed Inc.
Jul 21, 2026
Maintained: Buy
Price Target: $44.50 → $40.00
Current: $32.15
Upside: +24.44%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Buy
Price Target: $45.21 → $44.01
Current: $43.08
Upside: +2.15%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $180.00 → $106.31
Current: $167.91
Upside: -36.68%
Aroa Biosurgery Limited
May 3, 2026
Maintained: Buy
Price Target: $1.16 → $1.35
Current: $0.57
Upside: +136.84%
Cochlear Limited
Apr 29, 2026
Maintained: Buy
Price Target: $295.00 → $120.00
Current: $136.65
Upside: -12.18%
Monash IVF Group Limited
Apr 29, 2026
Maintained: Hold
Price Target: $0.69 → $0.86
Current: $0.73
Upside: +17.81%
Orthocell Limited
Apr 20, 2026
Maintained: Buy
Price Target: $1.33 → $1.26
Current: $0.81
Upside: +55.56%
SomnoMed Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.35
Upside: +185.71%
Mar 4, 2026
Maintained: Buy
Price Target: $5.43 → $5.55
Current: $3.57
Upside: +55.68%
Mar 4, 2026
Maintained: Buy
Price Target: $3.00 → $2.57
Current: $2.25
Upside: +14.22%
Feb 23, 2026
Maintained: Buy
Price Target: $1.62 → $1.58
Current: $1.07
Upside: +48.36%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.92
Upside: -17.81%
Feb 2, 2026
Maintained: Buy
Price Target: $0.07 → $0.06
Current: $0.01
Upside: +1,100.00%
Nov 18, 2025
Maintained: Buy
Price Target: $350.00
Current: $197.02
Upside: +77.65%
Nov 7, 2025
Maintained: Buy
Price Target: $0.85 → $0.80
Current: $0.28
Upside: +185.71%
Oct 3, 2025
Maintained: Hold
Price Target: $37.00
Current: $44.96
Upside: -17.70%
Sep 24, 2025
Maintained: Buy
Price Target: $32.84
Current: $10.45
Upside: +214.26%
Sep 11, 2025
Maintained: Buy
Price Target: $3.00 → $2.81
Current: $0.27
Upside: +940.74%
Sep 10, 2025
Maintained: Buy
Price Target: $1.20
Current: $0.05
Upside: +2,164.15%
Sep 2, 2025
Maintained: Buy
Price Target: $3.00
Current: $2.20
Upside: +36.67%
Aug 28, 2025
Maintained: Buy
Price Target: $26.50
Current: $22.47
Upside: +17.94%
Aug 8, 2025
Maintained: Buy
Price Target: $8.50
Current: $2.45
Upside: n/a
Mar 24, 2025
Maintained: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $3.28
Upside: n/a
Feb 21, 2023
Maintained: Hold
Price Target: $0.71 → $0.55
Current: $0.40
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $1.16
Upside: n/a
Aug 29, 2022
Maintained: Hold
Price Target: $0.50 → $0.55
Current: $0.11
Upside: n/a
Jun 1, 2022
Maintained: Buy
Price Target: $0.75
Current: $0.01
Upside: n/a